In regards to your post, trying to tie 1+1 together with Mallinckrodt and Oncolix. Perhaps it's the fact the Phase 1 clinical is scheduled to be completed in Feb 2019 as noted in the .gov website:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.